Genmab — September 2015
-
Det er hovedindholdet i artiklen.
-
"Genmab forventes at priority review i løbet af en uge" slutter artiklen af med.
-
(tom indlæg)
-
(tom indlæg)
-
Også 100% herfra......er helt klar til godkendelse af Dara..Smiler grådigt
-
det er cd38 konkurrenterne, dara er foran
-
desværre ser det ud til at US insisterer på at kravle i hullet igen i dag. Øvøv, sur røv!
-
Solesen vil du ikke gerne forklare lidt om hvordan de turboer virker da jeg er lidt nysgerrig.
-
læs kommentar især pat,s den 29 september. http://multiplemyelomablog.com/2014/09/which-new-myeloma-drug-will-the-fda-approve-next.html
-
Jeg har desværre ikke adgang til data http://medwatch.dk/secure/Medicinal___Biotek/article7985630.ece?utm_source=Feed&utm_medium=latest
-
Nå, den er også her +25% https://www.nordnet.dk/mux/web/analys/nyheter/visaNyhet.html?itemid=359574013&sourcecode=ddk
-
Elsker jeffries
-
Peter Welford er vores mand i dag
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind